Ubs Group Ag Htg Molecular Diagnostics, Inc Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.46 - $1.45 $1,828 - $5,762	-3,974 Reduced 99.35%	26 $0
Q1 2022 May 16, 2022	BUY	$1.39 - $5.51 $2,449 - $9,708	1,762 Added 78.73%	4,000 $6,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $5.97 $1,518 - $2,805	-470 Reduced 17.36%	2,238 $12,000
Q3 2021 Nov 15, 2021	BUY	$5.01 - $6.8 $13,271 - $18,013	2,649 Added 4489.83%	2,708 $15,000
Q2 2021 Aug 13, 2021	BUY	$3.52 - $5.98 $116 - $197	33 Added 126.92%	59 $0
Q1 2021 May 12, 2021	SELL	$4.99 - $7.83 $22,744 - $35,689	-4,558 Reduced 99.43%	26 $0
Q4 2020 Feb 11, 2021	BUY	$4.14 - $5.95 $18,977 - $27,274	4,584 New	4,584 $22,000

Ticker HTGM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 11,048,100
Market Cap $3.76M
Description
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.